Clinical Trial Update: Open Label Immunotherapy Trial for Breast Cancer [Phase 2]

View source ↗

Summary

Open-label Phase 2 immunotherapy trial for breast cancer undergoing ongoing updates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Immunitor LLC

Snippet

Sponsor: Immunitor LLC | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN